The patient carrier of mechanical support to the circle: what every cardiologist should know for the management of acute problems

被引:1
作者
Marini, Marco [1 ]
Raineri, Claudia [2 ]
Di Tano, Giuseppe [3 ]
Cipriani, Manlio [4 ]
Oliva, Fabrizio [4 ]
De Maria, Renata [5 ]
机构
[1] AO Osped Riuniti, SC Cardiol, Dipartimento Cardiovasc, Ancona, Italy
[2] IRCCS Policlin San Matteo, Div Cardiol, Pavia, Italy
[3] Azienda Ist Ospitalieri, UO Cardiol, Largo Priori 1, I-26100 Cremona, Italy
[4] AO Osped Niguarda Ca Granda, SC Cardiol Insufficienza Cardiaca & Trapianto 2, Milan, Italy
[5] AO Osped Niguarda Ca Granda, Dipartimento Cardiotoracovasc, Ist Fisiol Clin, CNR, Milan, Italy
关键词
Complications; Heart failure; Mechanical circulatory support;
D O I
10.1714/1335.14832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with advanced heart failure refractory to optimal medical treatment have a high mortality and a poor quality of life with frequent hospital admissions. The lack of alternative treatment options has prompted the development of mechanical circulatory support (MCS) devices, first as bridge to heart transplant and subsequently as destination therapy as a valid alternative to transplant. Last generation MCS devices are mechanically reliable and their management has become increasingly less complex. Nowadays, medium-term survival does not significantly differ between MCS and heart transplant recipients. MCS management programs require a multidisciplinary team to optimize the pathway leading to rehabilitation and improved quality of life and decrease the frequent occurrence of complications. However, in the near future with the growing number of implants, the chances for clinical cardiologists to come across a MCS recipient will increase. The management of general or acute problems will no longer be limited to tertiary implanting centers. A key issue to improve patient outcomes is the provision of a smooth and careful transition from the hospital environment to home care. The aim of this review is to start this process by providing basic notions and general indications through several scenarios of MCS recipients presenting to the emergency room for acute clinical problems.
引用
收藏
页码:659 / 668
页数:10
相关论文
共 60 条
[31]  
Demirozu Z.T., Radovancevic R., Hochman L.F., Et al., Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device, J Heart Lung Transplant, 30, pp. 849-853, (2011)
[32]  
Morgan J.A., Paone G., Nemeh H.W., Et al., Gastrointestinal bleeding with the Heart-Mate II left ventricular assist device, J Heart Lung Transplant, 31, pp. 715-718, (2012)
[33]  
Stern D.R., Kazam J., Edwards P., Et al., Increased incidence of gastrointestinal bleed-ng following implantation of the Heart-Mate II LVAD, J Card Surg, 25, pp. 352-356, (2010)
[34]  
Kushnir V.M., Sharma S., Ewald G.A., Et al., Evaluation of GI bleeding after implantation of left ventricular assist device, Gastrointest Endosc, 75, pp. 973-979, (2012)
[35]  
Pagani F.D., Miller L.W., Russell S.D., Et al., Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device, J Am Coll Cardiol, 54, pp. 312-321, (2009)
[36]  
Gordon R.J., Quagliarello B., Lowy F.D., Ventricular assist device-related infections, Lancet Infect Dis, 6, pp. 426-437, (2006)
[37]  
Rogers J.G., Bostic R.R., Tong K.B., Adam-Son R., Russo M., Slaughter M.S., Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy, Circ Heart Fail, 5, pp. 10-16, (2012)
[38]  
Allen S.J., Sidebotham D., Postoperative care and complications after ventricular assist device implantation, Best Pract Res Clin Anaesthesiol, 26, pp. 231-246, (2012)
[39]  
Potapov E.V., Stepanenko A., Krabatsch T., Hetzer R., Managing long-term complications of left ventricular assist device therapy, Curr Opin Cardiol, 26, pp. 237-244, (2011)
[40]  
Oswald H., Schultz-Wildelau C., Gardiw-Al A., Et al., Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients, Eur J Heart Fail, 12, pp. 593-599, (2010)